Retransplantation for recurrent hepatitis C

Positive aspects

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.

Original languageEnglish (US)
JournalLiver Transplantation
Volume9
Issue number11
DOIs
StatePublished - Jan 1 2003

Fingerprint

End Stage Liver Disease
Hepatitis C
Survival
Databases

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Cite this

Retransplantation for recurrent hepatitis C : Positive aspects. / McCashland, Timothy M.

In: Liver Transplantation, Vol. 9, No. 11, 01.01.2003.

Research output: Contribution to journalArticle

@article{7e4ad318678f4b88a9f3776f24d94b33,
title = "Retransplantation for recurrent hepatitis C: Positive aspects",
abstract = "Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40{\%}). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.",
author = "McCashland, {Timothy M}",
year = "2003",
month = "1",
day = "1",
doi = "10.1053/jlts.2003.50249",
language = "English (US)",
volume = "9",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Retransplantation for recurrent hepatitis C

T2 - Positive aspects

AU - McCashland, Timothy M

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.

AB - Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.

UR - http://www.scopus.com/inward/record.url?scp=0242456074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242456074&partnerID=8YFLogxK

U2 - 10.1053/jlts.2003.50249

DO - 10.1053/jlts.2003.50249

M3 - Article

VL - 9

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11

ER -